ENLIVEN THERAPEUTICS, INC.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2019 | — | $-4.2M | $-4.2M |
| Jun 2019 | — | $-5.6M | $-5.4M |
| Sep 2019 | — | $-6.9M | $-6.6M |
| Mar 2020 | — | $-7.4M | $-7.2M |
| Jun 2020 | — | $-10.3M | $-10.2M |
| Sep 2020 | — | $-12.5M | $-12.4M |
| Mar 2021 | — | $-10.3M | $-10.3M |
| Jun 2021 | — | $-13.2M | $-13.2M |
| Sep 2021 | — | $-13.7M | $-13.6M |
| Mar 2022 | — | $-8.7M | $-8.7M |
| Jun 2022 | — | $-9.0M | $-8.9M |
| Sep 2022 | — | $-10.9M | $-10.6M |
| Mar 2023 | — | $-16.4M | $-14.7M |
| Jun 2023 | — | $-20.1M | $-16.7M |
| Sep 2023 | — | $-24.2M | $-20.8M |
| Mar 2024 | — | $-26.0M | $-22.7M |
| Jun 2024 | — | $-24.6M | $-20.0M |
| Sep 2024 | — | $-27.1M | $-23.2M |
| Mar 2025 | — | $-31.7M | $-28.5M |
| Jun 2025 | — | $-28.6M | $-25.3M |
| Sep 2025 | — | $-25.1M | $-20.1M |
| Mar 2026 | — | $-27.8M | $-23.6M |
| Jun 2026 | — | $-37.2M | $-32.5M |